LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 7 of 497
Next
>>
>
151 to 175 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	GSK1059615	0.04	uM	LJP5	1	E06	72	hr	1097	3280	3769	0.8701	0.8168
BT-20	GSK1059615	0.04	uM	LJP5	2	E06	72	hr	1097	3795	3769	1.0068	1.0095
BT-20	GSK1059615	0.04	uM	LJP5	3	E06	72	hr	1097	3838	3769	1.0182	1.0256
BT-20	GSK1059615	0.04	uM	LJP6	1	C06	72	hr	1097	2996	3769	0.7948	0.7105
BT-20	GSK1059615	0.04	uM	LJP6	2	C06	72	hr	1097	3279	3769	0.8699	0.8164
BT-20	GSK1059615	0.04	uM	LJP6	3	C06	72	hr	1097	3040	3769	0.8065	0.7270
BT-20	GSK1904529A	0.04	uM	LJP6	1	H24	72	hr	1097	3142	3769	0.8335	0.7652
BT-20	GSK1904529A	0.04	uM	LJP6	2	H24	72	hr	1097	2961	3769	0.7855	0.6974
BT-20	GSK1904529A	0.04	uM	LJP6	3	H24	72	hr	1097	3238	3769	0.8590	0.8011
BT-20	Omipalisib	0.04	uM	LJP6	1	N06	72	hr	1097	740	3769	0.1963	-0.1337
BT-20	Omipalisib	0.04	uM	LJP6	2	N06	72	hr	1097	818	3769	0.2170	-0.1045
BT-20	Omipalisib	0.04	uM	LJP6	3	N06	72	hr	1097	776	3769	0.2059	-0.1202
BT-20	GSK 690693	0.04	uM	LJP5	1	F24	72	hr	1097	3428	3769	0.9094	0.8722
BT-20	GSK 690693	0.04	uM	LJP5	2	F24	72	hr	1097	3097	3769	0.8216	0.7483
BT-20	GSK 690693	0.04	uM	LJP5	3	F24	72	hr	1097	3193	3769	0.8471	0.7843
BT-20	GW843682X	0.04	uM	LJP6	1	B18	72	hr	1097	3153	3769	0.8364	0.7693
BT-20	GW843682X	0.04	uM	LJP6	2	B18	72	hr	1097	3204	3769	0.8500	0.7884
BT-20	GW843682X	0.04	uM	LJP6	3	B18	72	hr	1097	2663	3769	0.7065	0.5859
BT-20	HG-5-113-01	0.04	uM	LJP5	1	B12	72	hr	1097	3655	3769	0.9696	0.9571
BT-20	HG-5-113-01	0.04	uM	LJP5	2	B12	72	hr	1097	3839	3769	1.0184	1.0260
BT-20	HG-5-113-01	0.04	uM	LJP5	3	B12	72	hr	1097	4058	3769	1.0765	1.1079
BT-20	HG-5-88-01	0.04	uM	LJP6	1	A24	72	hr	1097	3078	3769	0.8166	0.7412
BT-20	HG-5-88-01	0.04	uM	LJP6	2	A24	72	hr	1097	2683	3769	0.7118	0.5934
BT-20	HG-5-88-01	0.04	uM	LJP6	3	A24	72	hr	1097	2954	3769	0.7837	0.6948
BT-20	Imatinib	0.04	uM	LJP6	1	N18	72	hr	1097	3763	3769	0.9983	0.9976

|<
<<
Previous
Page 7 of 497
Next
>>
>
151 to 175 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)